XML 43 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Segments and Geographic Data (Tables)
9 Months Ended
Sep. 30, 2016
Segment Reporting [Abstract]  
Schedule of results of operations from business segments

The following tables reflect results of operations from our business segments for the periods indicated below:

 

Three Months Ended September 30, 2016 (unaudited)

 

    CONSUMER     PHYSICIAN
RECURRING
    PROFESSIONAL     TOTAL  
Revenues   $ 6,142     $ 840     $ 276     $ 7,258  
Costs of revenues     909       461       117       1,487  
Gross profit     5,233       379       159       5,771  
Gross profit %     85.2 %     45.1 %     57.6 %     79.5 %
                                 
Allocated operating expenses:                                
Engineering and product development     243       83       -       326  
Selling and marketing expenses     3,921       591       17       4,529  
                                 
Impairment     3,518       -       -       3,518  
Loss on sale of assets     -       1,731       -       1,731  
Unallocated operating expenses     -       -       -       2,894  
      7,682       2,405       17       12,998  
Income (loss) from continuing operations     (2,449 )     (2,026 )     142       (7,227 )
                                 
Interest  and other financing income, net     -       -       -       88  
                                 
Income (loss) from continuing operations before income taxes   $ (2,449 )   $ (2,026 )   $ 142     $ (7,139 )

 

Three Months Ended September 30, 2015 (unaudited)

 

    CONSUMER     PHYSICIAN
RECURRING
    PROFESSIONAL     TOTAL  
Revenues   $ 15,994     $ 1,315     $ 689     $ 17,998  
Costs of revenues     3,348       525       468       4,341  
Gross profit     12,646       790       221       13,657  
Gross profit %     79.1 %     60.1 %     32.1 %     75.9 %
                                 
Allocated operating expenses:                                
Engineering and product development     245       19       (25 )     239  
Selling and marketing expenses     13,198       1,009       70       14,277  
                                 
Unallocated operating expenses     -       -       -       3,450  
      13,443       1,028       45       17,966  
Income (loss) from continuing operations     (797 )     (238 )     176       (4,309 )
                                 
Interest and other financing expense, net     -       -       -       (332 )
                                 
Income (loss) from continuing operations before income taxes   $ (797 )   $ (238 )   $ 176     $ (4,641 )

 

Nine Months Ended September 30, 2016 (unaudited)

 

    CONSUMER     PHYSICIAN
RECURRING
    PROFESSIONAL     TOTAL  
Revenues   $ 25,724     $ 3,302     $ 708     $ 29,734  
Costs of revenues     5,412       1,853       330       7,595  
Gross profit     20,312       1,449       378       22,139  
Gross profit %     79.0 %     43.9 %     53.4 %     74.5 %
                                 
Allocated operating expenses:                                
Engineering and product development     779       204       -       983  
Selling and marketing expenses     16,677       2,045       35       18,757  
                                 
Impairment     3,518       -       -       3,518  
Loss on sale of assets     -       1,731       843       2,574  
Unallocated operating expenses     -       -       -       9,791  
      20,974       3,980       878       35,623  
Income (loss) from continuing operations     (662 )     (2,531 )     (500 )     (13,484 )
                                 
Interest  and other financing expense, net     -       -       -       (537 )
                                 
Income (loss) from continuing operations before income taxes   $ (662 )   $ (2,531 )   $ (500 )   $ (14,021 )

 

Nine Months Ended September 30, 2015 (unaudited)

 

    CONSUMER     PHYSICIAN
RECURRING
    PROFESSIONAL     TOTAL  
Revenues   $ 51,659     $ 4,742     $ 2,194     $ 58,595  
Costs of revenues     10,922       1,807       1,185       13,914  
Gross profit     40,737       2,935       1,009       44,681  
Gross profit %     78.9 %     61.9 %     46.0 %     76.3 %
                                 
Allocated operating expenses:                                
Engineering and product development     874       77       16       967  
Selling and marketing expenses     43,023       3,099       249       46,371  
                                 
Unallocated operating expenses     -       -       -       12,463  
      43,897       3,176       265       59,801  
Income (loss) from continuing operations     (3,160 )     (241 )     744       (15,120 )
                                 
Interest and other financing expense, net     -       -       -       (936 )
                                 
Income (loss) from continuing operations before income taxes   $ (3,160 )   $ (241 )   $ 744     $ (16,056 )
Schedule of net revenues by geographic area

For the three and nine months ended September 30, 2016 and 2015 (unaudited), net revenues by geographic area were as follows:

 

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2016     2015     2016     2015  
North America 1   $ 4,257     $ 11,103     $ 18,376     $ 39,827  
Asia Pacific 2     744       1,147       2,180       3,403  
Europe (including Israel)     2,246       5,716       9,147       15,139  
South America     11       32       31       226  
    $ 7,258     $ 17,998     $ 29,734     $ 58,595  
                                 
1 United States   $ 3,528     $ 10,281     $ 15,405     $ 35,407  
1 Canada   $ 277     $ 822     $ 1,506     $ 4,420  
2 Japan   $ 8     $ 190     $ 8     $ 385  
Schedule of long-lived assets by geographic area

As of September 30, 2016 and December 31, 2015, long-lived assets by geographic area were as follows:

 

    September30, 2016     December 31, 2015  
    (unaudited)        
North America   $ 91     $ 169  
Asia Pacific     31       41  
Europe (including Israel)     929       1,096  
    $ 1,051     $ 1,306